Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Investment in securities market are subject to market risks. Read all the related documents carefully before investing

End of Year Sale!
Grab Our Small Cap Recommendation
Service at a 60% Discount




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Realty stocks lead the downfall
Fri, 11 May 11:30 am

Indian stock market indices continued to trade weak over the last two hours of trade on the back of heavy selling activity witnessed across industry heavyweights. Realty and FMCG stocks witnessed maximum selling pressure.

The BSE-Sensex is down by 150 points, while the NSE-Nifty is down by 48 points. BSE Mid cap index and the BSE Small cap index are down by 0.86% and 0.65% respoectively. The rupee is trading at 53.59 to the US dollar.

Pharma stocks are trading weak led by Orchid Chemicals and Sun Pharma. Cadila Healthcare has announced its results for the quarter ended March 2012. On a consolidated basis, the company reported a 3% YoY decline in net profits. This was mainly on account of foreign exchange losses. Total revenues for the company increased by 15% YoY. The company has also recommended a dividend of Rs 7.5 per share. During the quarter under consideration the group's India formulations business posted sales of Rs 4.9 bn, while its formulation export to US also registered robust growth. During the quarter the group also entered into an agreement with Microbix Biosystems Inc, to market the Thrombolytic drug, Urokinase in the American markets. The company filed eight abbreviated new drug applications (ANDAs) during the quarter to take the total filings to 148.

Power stocks are trading in the red led by Neyveli Lignite and Torrent Power. National Thermal Power Corporation (NTPC) has announced its results for the quarter ended March 2012. The company has reported a 6.8% YoY drop in net profits for the quarter ended March 2012. For the year ended March 2012, the company has reported a 5% YoY increase in net profit. Total income increased by 4.8% YoY for the quarter ended March 2012. NTPC reported higher annual profit despite its fuel cost, on a consolidated basis, soaring about 19% in the last fiscal. The company has recommended a final dividend of Rs 0.5 per share, taking the total dividend payout to Rs 4 per share for the year 2011-12.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Realty stocks lead the downfall". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.